Literature DB >> 17196751

Relationships between locomotor activation and alterations in brain temperature during selective blockade and stimulation of dopamine transmission.

P L Brown1, D Bae, E A Kiyatkin.   

Abstract

It is well known that the dopamine (DA) system plays an essential role in the organization and regulation of brain activational processes. Various environmental stimuli that induce locomotor activation also increase DA transmission, while DA antagonists decrease spontaneous locomotion. Our previous work supports close relationships between locomotor activation and brain and body temperature increases induced by salient environmental challenges or occurring during motivated behavior. While this correlation was also true for psychomotor stimulant drugs such as methamphetamine and MDMA, more complex relationships or even inverted correlations were found for other drugs that are known to increase DA transmission (i.e. heroin and cocaine). In the present study we examined brain, muscle and skin temperatures together with conventional locomotion during selective interruption of DA transmission induced by a mixture of D1 and D2 antagonists (SCH-23390 and eticlopride at 0.2 mg/kg, s.c.) and its selective activation by apomorphine (APO; 0.05 and 0.25 mg/kg, i.v.) in rats. While full DA receptor blockade decreased spontaneous locomotion, it significantly increased brain, muscle and skin temperatures, suggesting metabolic brain activation under conditions of vasodilatation (or weakening of normal vascular tone). In contrast, APO strongly decreased skin temperature but tended to decrease brain and muscle temperatures despite strong hyperlocomotion and stereotypy. The brain temperature response to APO was strongly dependent on basal brain temperature, with hypothermia at high basal temperatures and weak hyperthermia at low temperatures. While supporting the role of DA in locomotor activation, these data suggest more complex relationships between drug-induced alterations in DA transmission, behavioral activation and metabolic brain activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17196751      PMCID: PMC1850994          DOI: 10.1016/j.neuroscience.2006.11.028

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  47 in total

Review 1.  Electrophysiology of dopamine in normal and denervated striatal neurons.

Authors:  P Calabresi; D Centonze; G Bernardi
Journal:  Trends Neurosci       Date:  2000-10       Impact factor: 13.837

2.  Effects of haloperidol and clozapine on Fos expression in the primate striatum.

Authors:  David Wirtshafter; Karen E Asin
Journal:  Neuroreport       Date:  2003-12-19       Impact factor: 1.837

3.  Selected contribution: ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality.

Authors:  Andrej A Romanovsky; Andrei I Ivanov; Yury P Shimansky
Journal:  J Appl Physiol (1985)       Date:  2002-06

4.  Haloperidol induces Fos expression in the globus pallidus and substantia nigra of cynomolgus monkeys.

Authors:  D Wirtshafter; K E Asin
Journal:  Brain Res       Date:  1999-07-24       Impact factor: 3.252

5.  Brain hyperthermia is induced by methamphetamine and exacerbated by social interaction.

Authors:  P Leon Brown; Roy A Wise; Eugene A Kiyatkin
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

6.  Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions.

Authors:  P Leon Brown; Eugene A Kiyatkin
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

Review 7.  Dopamine in the nucleus accumbens: cellular actions, drug- and behavior-associated fluctuations, and a possible role in an organism's adaptive activity.

Authors:  Eugene A Kiyatkin
Journal:  Behav Brain Res       Date:  2002-12-02       Impact factor: 3.332

8.  Fluctuations in neural activity during cocaine self-administration: clues provided by brain thermorecording.

Authors:  E A Kiyatkin; P L Brown
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus.

Authors:  J Ma; N Ye; N Lange; B M Cohen
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Brain temperature fluctuation: a reflection of functional neural activation.

Authors:  Eugene A Kiyatkin; P Leon Brown; Roy A Wise
Journal:  Eur J Neurosci       Date:  2002-07       Impact factor: 3.386

View more
  6 in total

1.  Methamphetamine-induced behavioral and physiological effects in adolescent and adult HIV-1 transgenic rats.

Authors:  Marley D Kass; Xiangqian Liu; Michael Vigorito; Linda Chang; Sulie L Chang
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-09       Impact factor: 4.147

Review 2.  The hidden side of drug action: brain temperature changes induced by neuroactive drugs.

Authors:  Eugene A Kiyatkin
Journal:  Psychopharmacology (Berl)       Date:  2012-12-29       Impact factor: 4.530

3.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.

Authors:  Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2015-05-01       Impact factor: 4.530

4.  Differential effects of dopamine and opioid receptor blockade on motivated Coca-Cola drinking behavior and associated changes in brain, skin and muscle temperatures.

Authors:  E A Kiyatkin
Journal:  Neuroscience       Date:  2010-02-16       Impact factor: 3.590

5.  Brain temperature responses to salient stimuli persist during dopamine receptor blockade despite a blockade of locomotor responses.

Authors:  Eugene A Kiyatkin
Journal:  Pharmacol Biochem Behav       Date:  2008-08-08       Impact factor: 3.533

6.  Methamphetamine causes acute hyperthermia-dependent liver damage.

Authors:  Laura E Halpin; William T Gunning; Bryan K Yamamoto
Journal:  Pharmacol Res Perspect       Date:  2013-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.